Thursday, May 2, 2013

• Corcept Therapeutics Announces First Quarter 2013 Financial ResultsMarketwired( (Thu, May 2)

Friday, April 26, 2013

• Corcept Therapeutics to Announce First Quarter 2013 Financial Results and Host Conference CallMarketwired( (Fri, Apr 26)

Thursday, March 7, 2013

• Corcept Therapeutics Announces Fourth Quarter and Full Year 2012 Financial ResultsMarketwired( (Thu, Mar 7)

Thursday, February 28, 2013

• Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success in 2012Marketwired( (Thu, Feb 28)

Tuesday, February 12, 2013

• Corcept Therapeutics Announces Fourth Quarter and Full Year Revenue and Corporate UpdateMarketwired( (Tue, Feb 12)

Wednesday, January 23, 2013

• Merger and Acquisition Activity Expected to Rise in 2013 as Big Pharma Companies Flush With CashMarketwired( (Wed, Jan 23)

Thursday, December 6, 2012

• Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry's Success in 2012Marketwired( (Thu, Dec 6)

Wednesday, October 31, 2012

• Corcept Therapeutics Announces Third Quarter Results and Corporate UpdateMarketwired( (Wed, Oct 31)

Monday, October 15, 2012

• Corcept Therapeutics Appoints Daniel M. Bradbury to Board of DirectorsMarketwired( (Mon, Oct 15)

Tuesday, August 7, 2012

• Corcept Therapeutics Announces $30 Million Synthetic, Capped Royalty Transaction; Terminates Committed Equity Financing FacilityMarketwired( (Tue, Aug 7)
• Corcept Therapeutics Announces Second Quarter Results and Corporate UpdateMarketwired( (Tue, Aug 7)

Monday, July 2, 2012

• Corcept Therapeutics Announces Underwritten Public Offering of Common StockMarketwired( (Mon, Jul 2)
• Corcept Therapeutics Commences Public Offering of Common StockMarketwired( (Mon, Jul 2)